One of the LPDI's de novo protein binders (red) bound to the protein Bcl2 (blue) in complex with FDA-approved drug Venetoclax (beige) (IMAGE)
Ecole Polytechnique Fédérale de Lausanne
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.